Key Takeaways Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by Sanofi.French pharmaceutical giant Sanofi agreed to pay $8.00 per share in cash at closing,

The two embassy employees were killed by a gunman Wednesday night after an event at the Capital Jewish Museum.

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. With the biotech into the last year of its cash runway,

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company’s pipeline.

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co

Vigil Neuroscience shares more than tripled in premarket trading a day after Sanofi agreed to acquire Vigil for about $470 million. Vigil shares were trading around $8. The stock was up 36% on the year as of Wednesday's close.

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

At the corner of Pierce and Walnut streets, dozens stood with candles in hand to pay respect to Jasper Kyle McCoy, who died inside his home early Saturday.

A judge on Wednesday found four men not guilty in a violent brawl outside a South Side restaurant last summer, court records show.